Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21032520 | 0.97 | HSD17B10 (0.37) | HSD17B10ATMKDM4EL3MBTL1MEN1 | |
| SCHEMBL19130047 | 0.96 | HSD17B10 (0.36) | HSD17B10ATMKDM4EL3MBTL1MEN1 | |
| SCHEMBL31685 | 0.96 | HSD17B10 (0.36) | HSD17B10ATMKDM4EL3MBTL1MEN1 | |
| SCHEMBL19129711 | 0.95 | HSD17B10 (0.35) | HSD17B10ATMKDM4EL3MBTL1MEN1 | |
| SCHEMBL19129550 | 0.95 | HSD17B10 (0.35) | HSD17B10ATMKDM4EL3MBTL1MEN1 | |
| SCHEMBL19129704 | 0.94 | HSD17B10 (0.36) | HSD17B10ATMKDM4EL3MBTL1MEN1 | |
| SCHEMBL19130112 | 0.94 | HSD17B10 (0.36) | HSD17B10ATMKDM4EL3MBTL1MEN1 | |
| SCHEMBL16919403 | 0.94 | HSD17B10 (0.38) | HSD17B10ATMKDM4EL3MBTL1MEN1 | |
| SCHEMBL31717 | 0.93 | ATM (0.39) | HSD17B10ATMKDM4EL3MBTL1MEN1 | |
| SCHEMBL31770 | 0.93 | ATM (0.39) | HSD17B10ATMKDM4EL3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11387417-B2 | Organic electroluminescent device | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. | 2022-07-12 | — | — | US | disclosed |
| US-20200058882-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) | 2020-02-20 | — | — | US | disclosed |
| US-20170207396-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) | 2017-07-20 | — | — | US | disclosed |
| US-20170207396-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) | 2017-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11387417-B2 | Organic electroluminescent device | L3MBTL4, SLC39A14, CTCF | HSD17B10 1537/4885ATM 4085/4885KDM4E 3013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.